Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00000966 | A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS | PHASE1 | COMPLETED | 45 | — | — | - | - | Aug 26, 2008 | 11 | United States |
| Name | Type | Description |
|---|---|---|
| Azithromycin | DRUG | - |
| Pyrimethamine | DRUG | - |
| Leucovorin calcium | DRUG | - |
Inclusion Criteria Concurrent Medication: Allowed: * Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia (PCP). * Allowed during maintenance period (weeks 7 - 24): * Zidovudine and other antiretrovirals available through treatment IND mechanisms, ganciclovir, and mainte...